Projects

Since the year 2000, a concerted campaign against malaria has led to unprecedented levels of intervention coverage across sub-Saharan Africa

Mosquito vector data are collected in a myriad of different ways by multiple data collectors for a wide variety of purposes.

New research reveals a transformation of housing in sub-Saharan Africa, with the prevalence of improved housing doubling between 2000 and 2015.

WHO has approved and recommended the first malaria vaccine to be used for the prevention of P. falciparum malaria in children living in moderate to high transmission areas

This is a collaborative project between the Tanzanian National Institute for Medical Research (NIMR), the National Malaria Control Program (NMCP) and MAP.

This collaborative work between MAP, the Ifakara Health Institute (IHI) and the National Malaria Control Program (NMCP) in Tanzania

MAP is working in a collaborative partnership with the Zambia National Malaria Elimination Programme (NMEP) to provide broad ranging analytical support for malaria elimination in the country.

MAP is committed to playing a proactive role in contributing to enhanced research capacity and leadership in malaria endemic countries and to promote bilateral knowledge sharing.

This project will support entomological data collection of essential information on An. Stephensi bionomics and its susceptibility to the available malaria vector control methods in Sudan.

As many countries across meso-America come closer to elimination goals, understanding the transmission potential in areas where little to no transmission has occurred in the recent years becomes increasingly important to guide elimination and prevent local re-introduction of transmission

Enormous progress has been made in recent years in developing techniques for malaria genetic surveillance.

As Southern Angola aims to scale up their application of IRS, a targeted approach will allow
for maximal impact.

MAP and researchers in India are embarking on a project to create improved maps and burden estimates for malaria

In collaboration with Sudanese researchers and the Sudanese Ministry of Health, MAP created high-resolution maps and burden estimates of malaria burden in Sudan

MAP’s work on global drug and diagnostic use is supplemented by this project, done in partnership with the PMI:Insights consortium to answer case-management and commodity quantification questions raised by PMI teams based in Guinea, Mozambique, Uganda and Zambia.

MAP, in partnership with CHAI IVCC,Swiss TPH, MMV and RBM, has produced global forecasts of demand for important malaria commodities forward to 2031. MAP provided estimates of historical and projected need, demand and consumption of ITNs, RDTs and antimalarials including ACTs. 

MAP produces high-resolution estimates of Plasmodium falciparum prevalence, incidence, and mortality.

MAP produces high-resolution maps and burden estimates for Plasmodium vivax.

Seasonal Malaria Chemoprevention (SMC) is the monthly administration of antimalarials sulfadoxine-pyrimethamine and amodiaquine (SP + AQ) to children at risk during a country’s peak malaria season.

In this project, we generate high-resolution maps of the proportion of household sprayed with IRS annually across sub-Saharan Africa.

In this study, we generate high-resolution maps of ITN access, use and nets-per-capita annually across the 40 highest-burden African countries.

In this study, we generate high-resolution maps of ITN access, use, and nets-per-capita annually across the 40 highest-burden African countries.

Substantial progress has been made in reducing the burden of malaria in Africa since 2000, but those gains were jeopardised by the COVID-19 pandemic

Access to healthcare is a measure of human well-being that is constrained by numerous geographically-varying factors, the most immediate of which is the time it takes individuals to travel to a properly equipped and adequately staffed healthcare facility.

”High burden to high impact” is a country-led response – catalyzed by WHO and the RBM Partnership – to reignite the pace of progress in the global malaria fight.

Most malaria endemic countries experience seasonal variation in transmission.